Valuation DexCom, Inc. Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
01:30:01 10/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 72.10 EUR | -0.69% |
|
-6.46% | +26.97% |
| 07:05pm | DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM | |
| 25/08 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 31,898 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 23.23% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 31,137 | 30,837 | 30,022 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 18.81% | -0.96% | -2.64% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 33.9x | 28.5x | 23.5x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.2x | 9.35x | 7.2x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.1x | 5.5x | 4.94x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.95x | 5.32x | 4.65x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 18.7x | 16.1x | 13.5x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 25x | 21.3x | 17.4x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 30.5x | 25.3x | 20.4x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.28% | 3.96% | 4.89% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,920 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,445 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 84.53 | 84.53 | 84.53 |
| Nbr of stocks (in thousands) | 3,87,688 | 3,86,258 | 3,86,374 | 3,90,595 | 3,90,016 | 3,77,361 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.27x | 4.11x | 15.78x | 2.44% | 18TCr | |
| 19.54x | 3.57x | 12.75x | 3.07% | 12TCr | |
| 17.78x | 0.21x | 12.97x | 0.74% | 6.2TCr | |
| 28.6x | 7.04x | 18.13x | 1.4% | 5.06TCr | |
| 34.51x | 3.35x | 11.49x | 2.19% | 4.88TCr | |
| 33.88x | 5.95x | 18.69x | -.--% | 3.19TCr | |
| 44.79x | 1.3x | 12.02x | 0.21% | 3.04TCr | |
| 39.39x | 6.89x | 24.74x | 0.27% | 2.38TCr | |
| 17.34x | 2.76x | 9.79x | 1.6% | 2.23TCr | |
| Average | 29.57x | 3.91x | 15.15x | 1.32% | 6.34TCr | |
| Weighted average by Cap. | 27.76x | 3.78x | 14.79x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
